Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AVGO +18% (also increases dividend), RH +16.5%
Other news:
- GILD +10.6% (receives Positive CHMP Opinion for Primary Biliary Cholangitis)
- EVGO +8.7% (closes on $1.25 bln loan facility from the US Dept of Energy)
- LINC +6.2% (files $150 mln mixed shelf securities offering)
- BLND +4.9% (partners with PHH Mortgage)
- CAN +4% (to provide 2,000 Bitcoin mining machines to AGMH)
- VIR +3.5% (receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran)
- FPI +3% (declared a one-time dividend of $1.15/share)
- HWC +2.8% (authorizes new 5% share repurchase program)
- DCOM +2.7% (provides update on investment portfolio repositioning)
- BLKB +2.7% (discloses impairment charge)
- BGNE +2.6% (enters licensing agreement for MAT2A inhibitor)
- PLAY +2.6% (interim Chief Executive Officer bought 37,735 shares worth more than $960K)
- GERN +2.6% (announces positive CHMP opinion for RYTELO for the treatment of adults with transfusion-dependent anemia due to lower-risk MDS)
- ESPR +2.4% (Announces $210 Million Convertible Debt Financing)
- KOS +2.2% (issues statement regarding a possible all-share offer for Tullow Oil)
- MTSI +2.2% (refinances ~65% of existing Convertible Notes with new notes at 0% coupon and 27.5% conversion premium)
- PGY +1.7% (announces new $600 million consumer loan ABS Deal, underscoring strong momentum ahead of 2025)
- RWT +1.6% (increases dividend)
- STNG +1.6% (announces commitments for new $500.0 million revolving credit facility)
- NEU +1.5% (authorizes new $500 mln share repurchase program)
- DKL +1.5% (Announces FID on Acid Gas Injection "AGI" at the Libby Gas Complex, Incremental Crude Acreage Dedication and a Bolt-on Water Acquisition)
- DAR +1.4% (CFO to retire, names new CFO)
- NVDA +1.4% (Barron's out positive on NVDA)
- RDDT +1.3% (Texas Atty Gen launches investigations in Reddit, Instagram)
- CORT +1.2% (announces results in treatment phase of CATALYST trial)
- KEY +1.2% (KeyCorp and Scotiabank (BNS) receive approval to complete minority investment)
- HCM +1.1% (to receives $$10 mln milestone payment from Takeda (TAK) following first European reimbursement for FRUZAQLA)
- ORI +1.1% (declares special cash dividend of $2.00/share, payable on January 15, 2025)
- ZBH +1.1% (announces FDA 510(k) clearance for the OsseoFit Stemless Shoulder System)